Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF)

AIMS: Recurrent hospitalizations are a major part of the disease burden in heart failure (HF), but conventional analyses consider only the first event. We compared the effect of sacubitril/valsartan vs. enalapril on recurrent events, incorporating all HF hospitalizations and cardiovascular (CV) deat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogensen, Ulrik M., Gong, Jianjian, Jhund, Pardeep S., Shen, Li, Køber, Lars, Desai, Akshay S., Lefkowitz, Martin P., Packer, Milton, Rouleau, Jean L., Solomon, Scott D., Claggett, Brian L., Swedberg, Karl, Zile, Michael R., Mueller‐Velten, Guenther, McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Focus on Prognostic Variables
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607507/
https://www.ncbi.nlm.nih.gov/pubmed/29431251
http://dx.doi.org/10.1002/ejhf.1139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607507/
https://www.ncbi.nlm.nih.gov/pubmed/29431251
http://dx.doi.org/10.1002/ejhf.1139

Ejemplares similares